Assessing the In Vitro Suppressive Capacity of Regulatory T Cells

REFERENCES

• Allakhverdi Z., Fitzpatrick D., Boisvert A., Baba N., Bouguermouh S., Sarfati M., Delespesse G. Expression of CD103 identifies human regulatory T-cell subsets. J Allergy Clin Immunol 2006; 118: 1342–1349
   Google Scholar
• Annunziato F., Cosmi L., Liotta F., Lazzeri E., Manetti R., Vanini V., Romagnani P., Maggi E., Romagnani S. Phenotype, localization, and mechanism of suppression of CD4(+)CD25(+) human thymocytes. JExpMed 2002; 196: 379–387
   Google Scholar
• Bach J. F. Autoimmune diseases as the loss of active “self-control”. AnnNYAcadSci 2003; 998: 161–177
   PubMedGoogle Scholar
• Baecher-Allan C., Brown J. A., Freeman G. J., Hafler D. A. CD4+CD25high regulatory cells in human peripheral blood. JImmunol 2001; 167: 1245–1253
   PubMed Web of Science ®Google Scholar
• Baecher-Allan C., Brown J. A., Freeman G. J., Hafler D. A. CD4+CD25+ regulatory cells from human peripheral blood express very high levels of CD25 ex vivo. NovartisFoundSymp 2003; 252: 67–88
   Google Scholar
• Baecher-Allan C., Viglietta V., Hafler D. A. Human CD4+CD25+ regulatory T cells. SeminImmunol 2004; 16: 89–98
   Google Scholar
• Baecher-Allan C., Wolf E., Hafler D. A. MHC class II expression identifies functionally distinct human regulatory T cells. J Immunol 2006; 176: 4622–4631
   PubMed Web of Science ®Google Scholar
• Balandina A., Lecart S., Dartevelle P., Saoudi A., Berrih-Aknin S. Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis. Blood 2005; 105: 735–741
   PubMed Web of Science ®Google Scholar
• Battaglia M., Stabilini A., Roncarolo M. G. Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. Blood 2005; 105: 4743–4748
   PubMed Web of Science ®Google Scholar
• Bennett C. L., Christie J., Ramsdell F., Brunkow M. E., Ferguson P. J., Whitesell L., Kelly T. E., Saulsbury F. T., Chance P. F., Ochs H. D. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. NatGenet 2001; 27: 20–21
   Google Scholar
• Billiard F., Litvinova E., Saadoun D., Djelti F., Klatzmann D., Cohen J. L., Marodon G., Salomon B. L. Regulatory and effector T cell activation levels are prime determinants of in vivo immune regulation. J Immunol 2006; 177: 2167–2174
   PubMed Web of Science ®Google Scholar
• Bluestone J. A. Is CTLA-4 a master switch for peripheral T cell tolerance?. JImmunol 1997; 158: 1989–1993
   PubMed Web of Science ®Google Scholar
• Bluestone J. A., Tang Q. Therapeutic vaccination using CD4+CD25+ antigen-specific regulatory T cells. ProcNatlAcadSciUSA. 2004; 101(Suppl 2)14622–6
   PubMedGoogle Scholar
• Brunkow M. E., Jeffery E. W., Hjerrild K. A., Paeper B., Clark L. B., Yasayko S. A., Wilkinson J. E., Galas D., Ziegler S. F., Ramsdell F. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. NatGenet 2001; 27: 68–73
   Google Scholar
• Brusko T., Wasserfall C., McGrail K., Schatz R., Viener H. L., Schatz D., Haller M., Rockell J., Gottlieb P., Clare-Salzler M., Atkinson M. No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes. Diabetes 2007; 56: 604–612
   PubMed Web of Science ®Google Scholar
• Brusko T. M., Wasserfall C. H., Clare-Salzler M. J., Schatz D. A., Atkinson M. A. Functional defects and the influence of age on the frequency of CD4+ CD25+ T-cells in type 1 diabetes. Diabetes 2005; 54: 1407–1414
   PubMed Web of Science ®Google Scholar
• Deaglio S., Dwyer K. M., Gao W., Friedman D., Usheva A., Erat A., Chen J. F., Enjyoji K., Linden J., Oukka M., et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med. 2007; 204(6)1257–1265
   PubMed Web of Science ®Google Scholar
• Duggleby R. C., Shaw T. N., Jarvis L. B., Kaur G., Hill Gaston J. S. CD27 expression discriminates between regulatory and non-regulatory cells after expansion of human peripheral blood CD4(+) CD25(+) cells. Immunology 2007; 121: 129–139
   PubMedGoogle Scholar
• Eddahri F., Oldenhove G., Denanglaire S., Urbain J., Leo O., Andris F. CD4+ CD25+ regulatory T cells control the magnitude of T-dependent humoral immune responses to exogenous antigens. Eur J Immunol 2006; 36: 855–863
   PubMed Web of Science ®Google Scholar
• Fontenot J. D., Gavin M. A., Rudensky A. Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. NatImmunol 2003; 4: 330–336
   Google Scholar
• Fontenot J. D., Rasmussen J. P., Gavin M. A., Rudensky A. Y. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol 2005; 6: 1142–1151
   PubMed Web of Science ®Google Scholar
• Givan A. L., Fisher J. L., Waugh M. G., Ernstoff M. S., Wallace P. K. A flow cytometric method to estimate the precursor frequencies of cells proliferating in response to specific antigens. J. Immunol. Methods 1999; 230(1–2)99–112
   Google Scholar
• Hoffmann P., Eder R., Boeld T. J., Doser K., Piseshka B., Andreesen R., Edinger M. Only the CD45RA+ subpopulation of CD4+CD25high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion. Blood 2006; 108: 4260–4267
   PubMed Web of Science ®Google Scholar
• Hoffmann P., Eder R., Kunz-Schughart L. A., Andreesen R., Edinger M. Large-scale in vitro expansion of polyclonal human CD4(+)CD25high regulatory T cells. Blood 2004; 104: 895–903
   PubMed Web of Science ®Google Scholar
• Huan J., Culbertson N., Spencer L., Bartholomew R., Burrows G. G., Chou Y. K., Bourdette D., Ziegler S. F., Offner H., Vandenbark A. A. Decreased FOXP3 levels in multiple sclerosis patients. J Neurosci Res 2005; 81: 45–52
   PubMed Web of Science ®Google Scholar
• June C. H., Blazar B. R. Clinical application of expanded CD4+25+ cells. Semin Immunol 2006; 18: 78–88
   PubMed Web of Science ®Google Scholar
• Kamanaka M., Kim S. T., Wan Y. Y., Sutterwala F. S., Lara-Tejero M., Galan J. E., Harhaj E., Flavell R. A. Expression of interleukin-10 in intestinal lymphocytes detected by an interleukin-10 reporter knockin tiger mouse. Immunity 2006; 25: 941–952
   PubMed Web of Science ®Google Scholar
• Korn T., Bettelli E., Gao W., Awasthi A., Jager A., Strom T. B., Oukka M., Kuchroo V. K. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 2007; 448: 484–487
   PubMed Web of Science ®Google Scholar
• Levings M. K., Allan S., d'Hennezel E., Piccirillo C. A. Functional dynamics of naturally occurring regulatory T cells in health and autoimmunity. Adv Immunol 2006; 92: 119–155
   Google Scholar
• Liu W., Putnam A. L., Xu-Yu Z., Szot G. L., Lee M. R., Zhu S., Gottlieb P. A., Kapranov P., Gingeras T. R., de St Groth B. F., et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 2006; 203: 1701–1711
   PubMed Web of Science ®Google Scholar
• McHugh R. S., Whitters M. J., Piccirillo C. A., Young D. A., Shevach E. M., Collins M., Byrne M. C. CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 2002; 16: 311–323
   PubMed Web of Science ®Google Scholar
• Mempel T. R., Pittet M. J., Khazaie K., Weninger W., Weissleder R., von Boehmer H., von Andrian U. H. Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation. Immunity 2006; 25: 129–141
   Google Scholar
• Pasare C., Medzhitov R. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 2003; 299: 1033–1036
   PubMed Web of Science ®Google Scholar
• Piccirillo C. A., Shevach E. M. Naturally-occurring CD4+CD25+ immunoregulatory T cells: central players in the arena of peripheral tolerance. SeminImmunol 2004; 16: 81–88
   Google Scholar
• Roncarolo M. G., Gregori S., Battaglia M., Bacchetta R., Fleischhauer K., Levings M. K. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol Rev 2006; 212: 28–50
   PubMed Web of Science ®Google Scholar
• Sakaguchi S. Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. AnnuRevImmunol 2004; 22: 531–562
   Google Scholar
• Sakaguchi S., Sakaguchi N., Asano M., Itoh M., Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. JImmunol 1995; 155: 1151–1164
   PubMed Web of Science ®Google Scholar
• Seddiki N., Santner-Nanan B., Martinson J., Zaunders J., Sasson S., Landay A., Solomon M., Selby W., Alexander S. I., Nanan R., et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 2006; 203: 1693–1700
   PubMed Web of Science ®Google Scholar
• Shevach E. M. CD4+ CD25+ suppressor T cells: more questions than answers. NatRevImmunol 2002; 2: 389–400
   Google Scholar
• Shimizu J., Yamazaki S., Takahashi T., Ishida Y., Sakaguchi S. Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. NatImmunol 2002; 3: 135–142
   Google Scholar
• Shultz L. D., Ishikawa F., Greiner D. L. Humanized mice in translational biomedical research. Nat Rev Immunol 2007; 7: 118–130
   PubMed Web of Science ®Google Scholar
• Strauss L., Whiteside T. L., Knights A., Bergmann C., Knuth A., Zippelius A. Selective survival of naturally occurring human CD4+CD25+Foxp3+ regulatory T cells cultured with rapamycin. J Immunol 2007; 178: 320–329
   PubMed Web of Science ®Google Scholar
• Taams L. S., Boot E. P., van Eden W., Wauben M. H. ‘Anergic’ T cells modulate the T-cell activating capacity of antigen-presenting cells. J Autoimmun 2000; 14: 335–341
   Google Scholar
• Tang Q., Adams J. Y., Tooley A. J., Bi M., Fife B. T., Serra P., Santamaria P., Locksley R. M., Krummel M. F., Bluestone J. A. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat Immunol 2006; 7: 83–92
   PubMed Web of Science ®Google Scholar
• Tang Q., Krummel M. F. Imaging the function of regulatory T cells in vivo. Curr Opin Immunol 2006; 18: 496–502
   PubMed Web of Science ®Google Scholar
• Thornton A. M., Shevach E. M. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. JExpMed 1998; 188: 287–296
   Google Scholar
• Thornton A. M., Shevach E. M. Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific. JImmunol 2000; 164: 183–190
   PubMed Web of Science ®Google Scholar
• Tran D. Q., Ramsey H., Shevach E. M. Induction of FOXP3 expression in naive human CD4+FOXP3- T cells by T cell receptor stimulation is TGF{beta}-dependent but does not confer a regulatory phenotype. Blood. 2007, (e-pub ahead of print)
   Google Scholar
• Venken K., Thewissen M., Hellings N., Somers V., Hensen K., Rummens J. L., Stinissen P. A CFSE based assay for measuring CD4+CD25+ regulatory T cell mediated suppression of auto-antigen specific and polyclonal T cell responses. J Immunol Methods 2007; 322: 1–11
   PubMed Web of Science ®Google Scholar
• Weiner H. L. Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells. Immunol Rev 2001; 182: 207–214
   PubMed Web of Science ®Google Scholar
• Ziegler S. F. FOXP3: of mice and men. Annu Rev Immunol 2006; 24: 209–226
   PubMed Web of Science ®Google Scholar